Compounding Chemotherapy Market to Reach $6.3 Billion by 2027 in the short run and $9.8 Billion by 2034 Globally, at 6.4% CAGR: Allied Market Research ...

Many Americans have turned to compounding pharmacies to get popular weight-loss drugs due to lack of availability or expensive retail price tags. But this option will soon close for consumers. The ...

Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and possible side effects in compounded meds. Lifestyle habits—like diet, ...

Forbes Health has ranked the best providers for pricing, patient care, effectiveness and ease of use. This way you can cut through the scams and noise to make an informed decision when choosing an ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. In April 2025, the U.S. Food and Drug Administration ...

The White House may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably heard of them under brand names like Ozempi c® and Wegovy® (semaglutide) ...

Discover how compounding pharmacies are transforming healthcare by creating tailor-made medications for patients with unique needs, offering critical alternatives when standard drugs fall short, and ...

Compounded medication manufacturer CurifyLabs has released its next-generation software platform to provide pharmacists with ...